Madison Brown
Medical · Dendron, VANPI 1992181036
Payments from drug & device makers
Across 229 payments — averaging $15.38 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Lundbeck LLC$373
- Incyte Corporation$229
- GSK$173
- Teva Pharmaceuticals USA, Inc.$141
- Axsome Therapeutics, Inc.$121
- plus $1000 from 18 others
What the payments were for
- Food & beverage$3,523100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 139 | $1,487 |
| Lundbeck LLC | 23 | $373 |
| Incyte Corporation | 2 | $229 |
| GSK | 4 | $173 |
| Teva Pharmaceuticals USA, Inc. | 5 | $141 |
| Axsome Therapeutics, Inc. | 5 | $121 |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $104 |
| Pfizer | 5 | $101 |
| Corcept Therapeutics | 4 | $91 |
| Supernus Pharmaceuticals, Inc. | 5 | $84 |
| Biohaven Pharmaceuticals, Inc. | 3 | $84 |
| Biohaven Pharmaceutical Holding Company Ltd. | 4 | $81 |
| Bausch Health US, LLC | 3 | $61 |
| Amgen | 3 | $56 |
| Avanir Pharmaceuticals, Inc. | 3 | $55 |
| Impel Pharmaceuticals Inc. | 3 | $47 |
| Novo Nordisk | 2 | $44 |
| Jazz Pharmaceuticals Inc. | 2 | $42 |
| Lilly USA, LLC | 2 | $36 |
| AstraZeneca | 2 | $27 |
| Avanos Medical | 1 | $23 |
| Corium, LLC | 1 | $22 |
| Biogen | 1 | $22 |
| Exact Sciences | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- TRELEGY ELLIPTA$121
- OPZELURA$116
- PEMAZYRE$112
How this compares
$3,523 in reported general payments places this provider in the 80th percentile of 632 medical providers in Virginia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Aimovig AutoinjectorErenumab-Aooe | 13 | $9,258 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 22 | $655 |
| Aripiprazole | 14 | $495 |
| Duloxetine Hcl | 15 | $350 |
| Venlafaxine Hcl ErVenlafaxine Hcl | 18 | $232 |
| Gabapentin | 17 | $224 |
| Pregabalin | 12 | $181 |
| Valsartan | 14 | $179 |
| Fluoxetine Hcl | 22 | $176 |
| Trazodone Hcl | 21 | $149 |
| Atorvastatin Calcium | 19 | $137 |
| Quetiapine Fumarate | 12 | $131 |
| Amlodipine Besylate | 30 | $86 |
| Montelukast Sodium | 15 | $53 |
| Azithromycin | 12 | $29 |
Paid to pharmacies, not to this prescriber.
Other medical in Dendron
- Bryan UrquhartFredericksburg$264K
- Sara VillalonaRichmond$240K
- Sarah SafaLansdowne$171K
- Waseem GarbiaFairfax$114K
- Rana HassanAshburn$54K
- Brian LamFalls Church$51K
- Christine KesslerKing George$20K
- Janlyn AnthonyRichmond$18K
- Cara DepanfilisNorfolk$17K
- Nicholas DeptulaRichmond$17K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.